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Abstract 
To obtain key sugar derivatives of making homooligomeric foldamers or α/β-chimera peptides, 
economic and multigram scale synthetic methods were to be developed. Though described in the 
literature, the cost-effective making of both 3-amino-3-deoxy-ribofuranuronic acid (H-tX-OH) and its 
C-3 epimeric stereoisomer, the 3-amino-3-deoxy-xylofuranuronic acid (H-cX-OH) from D-glucose is 
described here. The present synthetic route elaborated is i) appropriate for large-scale synthesis, ii) 
reagent costs reduced (e.g. by a factor of 400), iii) yields optimized are ~80% or higher for all six 
consecutive steps concluding -tX- or -cX- and iv) reaction times shortened. Thus, a new synthetic 
route step-by-step optimized for yield, cost, time and purification is given both for D-xylo and D-ribo-
amino-furanuronic acids using sustainable chemistry (e.g. less chromatography with organic solvents; 
using continuous flow reactor). Multigram scale syntheses of these β-sugar amino acids, β-SAAs, now 
available on a larger scale made possible to test and optimize coupling reactions and conditions of 
making α/β-chimera peptides. Our study encompasses necessary building blocks (e.g. –X-OMe, –X-
O
i
Pr, –X–NHMe, Fmoc-X-OH) and key coupling reactions making –Aaa–tX–Aaa– or –Aaa–tX–tX–
Aaa– type “inserts”. Completed for both stereoisomers of X, including the newly synthetized Fmoc-
cX-OH, producing longer oligomers for drug design and discovery is more of a reality than a wish. 
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Graphical abstract: From D-glucose in 6 (7) steps both C-3 epimers of an azido-furanuronic acid 
(cAFU and tAFU) are obtained. Yield optimized, scalable and robust reactions made possible to get β-
sugar amino acids in a more environment-friendly way. Useful derivatives were synthesized and 
probed as key intermediates of foldameric “Lego element” now ready to be built in into α/β-chimera 
peptides supporting drug design and discovery. 
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Introduction 
Chimeric synthetic polypeptides composed of α/β-peptide units are copolymers of emerging 
significance (Cheng 2001; Horne 2008; Pilsl 2011; Guichard 2011). Especially, those composed of 
functionalized cyclobutane
 
(Declerck 2011; Gorrea 2012; Pohl 2013; Altmayer-Henzien 2015),  
cyclopentane
 
and cyclohexane
 
(Martinek 2012) derivatives have biological importance and 
perspectives (Cabrele 2014; Mándity 2015). To a great extent, the introduced none natural amino acid 
derivatives (e.g. ACPC, ACHC) contain the same number of torsional angles (φ and ψ) as α-peptides 
do, two per residue, however their backbone conformational behaviour is primarily determined by 
local configurational properties. Reduced mobility, if the conformation is carefully designed could 
increase binding ability of the polypeptide to other macromolecules, receptors and thus enhance 
bioactivity. 
Cis and trans stereoisomers of both 2-aminocyclopentanecarboxylic acid (ACPC) and 2-
aminocyclohexanecarboxylic acid (ACHC) derivatives are now extensively used to design chimeras in 
conjunction with acyclic γ- and/or δ- amino acid residues (Cabrele 2014; Giuliano 2013).  However, as 
both ACPC and ACHC derivatives are hydrophobic, their hydrophilic related compounds would be of 
great relevance, not yet fully explored (Hetényi 2009). Thus, their sugar analogues, called sugar amino 
acids (β-SAAs) are generally soluble in water. Also they would have similar conformational properties 
so they present considerable synthetic challenges. 
Among β-furanoid sugar amino acids, 1,2-O-isopropylidene-3-amino-3-deoxy-α-D-ribofuranuronic 
acid  (H-RibAFU(ip)-OH, -tX-, 1) and its C-3 epimer, H-XylAFU(ip)-OH, (-cX-, 2) have attracted 
special attention (Figure 1). The small scale synthesis of the N-protected derivatives of 1 and 2 from 
diaceton-glucofuranose (3) was described in various quantities (Gruner 2001; Gruner, Truffault et al. 
2002; Gruner, Locardi et al. 2002; Chandrasekhar 2004).  Conditions of these syntheses are different 
and the results are sometimes poor. 
 
Figure 1. 
Therefore, the ultimate goal of the present work was to find an efficient and economical synthetic 
pathway of multigram scale and high yield preparation of both C-3 epimers (1 and 2) (Scheme 1). Key 
of this synthetic route is the introduction of the -NH2 group, in other words making the N-terminal of 
the amino acid at the C-3 carbon atom: often a reduction following the sulfonate→azide replacement. 
Scheme 1. 
The importance of these nucleophilic substitutions is underlined by the review of Hale and Hough
 
(2015). This synthetic problem is of a challenge and merits a careful evaluation of the conditions. 
Consequently, the purpose of trying various alternative routes using low-cost chemicals, “greener” 
chemistry, giving higher yields is well-founded. In addition, we have elaborated synthetic routes 
converting both azido uronic acids (6 and 7) into key derivatives essential either for solid phase and in 
solution state peptide chemistry (e.g. Boc- , Fmoc- ) as well as preliminary coupling reactions were 
conducted making di- and triamide nanosystems. 
 
Therefore our primary interest was to make both H-tX-OH and H-cX-OH β-sugar amino acids as well 
as the following key derivatives needed for solid phase and/or solution state synthesis: 
1) C-terminal temporarily protected residue (e.g. -tX-OMe, -tX-O
i
Pr)  
2) the “next residue” mimicking C-terminal amide bond (e.g. -cX-NHMe and -tX-NHMe), 
3) N- terminal temporarily protected residue (e.g. Fmoc-cX- and Fmoc-tX-) were made.  
4) Finally “insert”, N3-tX-tX-NHMe was synthesized to be ligated or elongated directly upon request.  
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Results and discussion 
In order to achieve our goal to find more efficient and economical way for multigram scale synthesis 
of foldameric intermediate product 1 and 2 starting from D-glucose via diaceton-glucofuranose (3), the 
key step of the synthesis, the sulfonate ester → azide replacement had to be optimized. This 
transformation was performed earlier from various sulphonate esters under different conditions and in 
widely unlike scales. Consequently, one cannot find a comparative estimate of the published data 
which would establish the most reasonable and economic conditions for the synthesis of either the 3-
azido-3-deoxy-allofuranose or the epimeric glucofuranose derivatives. In addition, although the 
synthesis of the N-protected sugar amino acid is described (Gruner 2001; Gruner, Truffault et al. 2002; 
Gruner, Locardi et al. 2002), the important intermediate free sugar amino acid 1 was not yet isolated 
and characterized. 
Hence, we accomplished alternative routes with different sulfonate esters and under various reaction 
conditions, then we evaluated the results to choose the most advantageous protocol for producing both 
the 3-azido-3-deoxy-allo compound 4 (A, B, C, D) and the 3-azido-3-deoxy-gluco epimer 5 (E, F, G, 
H) (Scheme 2 and Scheme 3) in multigram scale. Application of known synthetic methods was 
combined with reagent modification and yield optimization. By introducing mild reaction conditions, 
excluding column chromatography when possible resulted in ways to use less organic solvent and thus 
making our chemistry less polluting.  
 
A) Synthesis of N3-RibAFU(ip)-OH (6) and N3-XylAFU(ip)-OH (7) 
Making 1,2:5,6-di-O-isopropylidene-3-azido-3-deoxy-α-D-allofuranose (4) is the key step for which 
the sulfonate ester (8, 9, 10, 11) → azide replacement (Scheme 2) had to be achieved.  
 
 
Scheme 2. 
 
Following Gruner's suggestions
 
(Gruner, Truffault et al. 2002) Route A via 3-O-
trifluoromethanesulfonyl intermediate (8) was found to be effective (≈16 h, T=20ºC) as 
trifluormethanesulfonate is an excellent leaving group. However, this approach has drawbacks and 
disadvantages: i) the reagent Tf2O is expensive and environment unfriendly, ii) intermediate triflate (8) 
is unstable and thus, hard to store. Route B via 3-O-methanesulfonyl intermediate (9) was modified by 
carrying out in DMSO instead of DMF (Ferreira 2010). Compared to Tf2O, MsCl is a less expensive 
reagent, however, the reactivity of mesylate 9 was lower requiring higher temperature and longer time 
(≈181 h, T= 140 °C). In Route C via 3-O-toluene-sulfonyl intermediate (10), Whistler's work was 
modified (Nayak and Whistler 1969), since we found that the reaction was faster in DMSO. Reaction 
time (≈54 h, T=140 °C) was about one seventh of the one published in DMF (360 h). In some cases, 
the influence of catalysts (Bu4N-salts) or solvent (DMSO – water) was investigated, but their effect 
was found to be insignificant with respect to the overall yield. Route D via 3-O-(N-imidazole-1-
sulfonyl)-derivative (11), with modification of Vatéle's work (Vatéle 1996), was carried out in DMSO 
instead of toluene and resulted in better yield. The advantages of this route are overwhelming: i) the 
reagent N,N'-sulfuryl-diimidazole is easily prepared and far less expensive than Tf2O, ii) the 
intermediate 11 is a crystalline and very stable product, iii) the formation of the azide 4 is fast (≈10 h, 
T=80°C) and the yield is excellent (72%). The latter yield found as an average after several repeats is 
higher than the one obtained in Gruner's experiment (A) and Vatéle's works (Vatéle 1996). The 
general problem of the above synthetic routes starting from sulfonate intermediates of gluco 
configuration (8, 9, 10, 11) is that the 3-O-sulfonate group and the H-4 atom are in relative trans 
(antiperiplanar) position. Thus, under nucleophilic conditions trans-elimination of the corresponding 
sulfonic acids can not be prevented and the result is the formation of the unsaturated side product 
1,2:5,6-di-O-isopropylidene-3-deoxy-α-D-eritro-hex-3-enofuranose (12). The ratio of side product 12 
varied in total between 3 and 36 % when syntheses were repeated. 
The synthetic route yielding 5 (1,2:5,6-di-O-isopropylidene-3-azido-3-deoxy-α-D-
glucofuranose) is longer as two additional steps are needed when compared with that making 4: 
5 
 
transformation of diaceton-glucofuranose (3) into diaceton-allofuranose (13) via the inversion of C-3 
by oxido-reduction lengthens the protocol. Among the tested oxidation methods, either oxidation with 
PCC, or oxidation with TEMPO / BAIB was found to be the most effective. The sulfonate→azide 
replacement was conducted (Scheme 3) by using various 3-O-sulfonyl derivatives, like the triflate 
(14), the mesylate (15), the tosylate (16), and the imidazylate (17). 
 
Scheme 3. 
 
The reactions with 14, 15 and 16 were carried out with modification of the earlier described methods 
(Ferreira 2010; Austin 1987), by using DMSO instead of DMF. Although the 3-O-imidazol-sulfonate 
ester 17 was known in the literature, its transformation into 5 has not been earlier executed. In Route 
H compound 17 gave the main product 5 with excellent yield, also in multigram scale. 
In summary, comparison of the yields of the allo compound 4 with those of the gluco 
compound 5 points out that data were higher for the latter almost in all cases. The main reason is that 
in the gluco sulfonate esters the configuration of the C-3 is opposite to that of allo derivatives. Hence, 
structural conditions for the elimination reaction producing unsaturated 12 are not given. In Table 1 
the effectiveness of the various synthetic paths for the azides 4 and 5 are compared. 
 
Table 1. 
In conclusion, Routes B and C are less expensive ways than Route A, however, due to the low yield 
and the long reaction time, they are not good alternatives. Following Route D via 3-OIms-derivative 
(11) both costs (<1/400
th) and reaction time (10 h ≈ 2/3) can be lowered significantly, moreover yield 
turned out to be excellent (72%) and thus this is the method of choice, appropriate for large-scale 
synthesis (Table 1). Similarly, route H via 3-OIms-derivative (17) was found to be the most suitable 
one for large-scale synthesis of 5, as both cost (1/400
th
) and reaction time (8 h ≈ 2/5) are lower than 
that of route E of the described alternative (Austin 1987). In addition, yield was almost excellent 
(90%) (Table 1). In addition Route H avoids the use of the environment unfriendly Tf2O and 
introduced an easily isolable and stable intermediate 17. 
 
Substituent effect of C-4 on the 3-O-sulfonate  azide replacement reaction 
In all cases of sulfonate → azide replacement the yield of the 3-azido-3-deoxy-allofuranose product 
(4) was influenced by the trans elimination of the different sulfonic acid derivatives under basic 
conditions: furnishing the undesired 3,4-unsaturated derivative 12 (Watterson 1999). The chance of 
the trans elimination is controlled by the partial positive charge of H-4, determined by electronic 
and/or steric effect of the substituent at C-4 due to its proximity to the reaction centre. To elucidate 
this influence we compared the reaction of six derivatives having three different substituents at C-4. 
During the removal of the 5,6-O-isopropylidene protecting group of 3-O-(N-imidazole-1-sulfonyl)-
derivative (11) unexpected synthetic challenges occurred (Szaniszló et al. to be published), the 
reaction with the 3-O-toluene-sulfonyl intermediate (10) is discussed here.  
 
Scheme 4. 
 
The –OTs → –N3 replacement reactions of gluco derivative 1,2:5,6-di-O-isopropylidene-3-O-sulfonate 
(10, Scheme 4) and the derived partially unprotected 1,2-O-isopropylidene-3-O-sulfonate (18) yield 
the target 3-azido-3-deoxy compounds (4 and 19) and the 3,4-unsaturated side products (12 and 20) 
similarly. Thus, in both cases the steric effect determines the product primarily. In contrast to this, 
starting from 21 the exclusive formation of the corresponding unsaturated side product 22 (90%) is 
explained by the strong electron withdrawing effect of -COOCH3 group, remarkably increasing the 
partially positive charge of H-4. In the parallel reactions of the corresponding allo derivatives (16, 23 
and 24) the relative cis configuration of substituents at C-3 and C-4 gives no a priori possibility of the 
trans elimination. The expectation fulfilled both for 16 and 23, where no 3,4-unsaturated side products 
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were detected. At the same time, ester 24 afforded exclusively the 3,4-unsaturated compound 22 
(92%) also isolated from the similar reaction of 21. The reason for this feature is, the electronic effect 
of -COOCH3 group is sufficiently strong to induce the cis elimination of toluenesulfonic acid, giving 
22 as the main product. Hence, 3-O-sulfonate → azide replacement for both gluco and allo series is 
advantageously executed at the beginning of the reaction pathway, preferably on 1,2:5,6-di-O-
isopropylidene compounds. 
The formation of the unsaturated by-product 12 brings with the technical difficulty of its separation 
from the main product 4. The column chromatography used by Vatéle and Hanessian (1996) was an 
appropriate choice for small quantities such as 300 mg, but not when synthesis is made on a larger 
scale. Therefore, we have reconsidered the purification process and have developed the following 
alternative working up, clearly more economic and environmentally friendly. The rough product was 
treated with KMnO4 to oxidize the unsaturated by-product 12 into a vicinal diol and the water soluble 
derivative easily extracted into the water phase. This improvement omitted the use of any 
chromatography (see Materials and methods). 
  
Transformation of gluco and allo 3-azido-3-deoxy intermediates (4 and 5) into N3-RibAFU(ip)-OH 
and N3-XylAFU(ip)-OH 
 
Selective removal of 5,6-O-isopropylidene protecting group of both trans and cis intermediates (4 and 
5) with the conventional procedure
 
(Zsoldos-Mády 1986) resulted in the 5,6-dihydroxy-derivatives (19 
and 25). After oxidative cleavage of diol compounds with sodium metaperiodate, the oxidation of the 
aldehydes was in situ performed into the carboxylic acids 6 and 7 (Scheme 5).  
 
Scheme 5. 
 
In conclusion, in line with Scheme 6 we propose the following reaction route, all steps now optimized 
using reagents of low costs, with unavoidable side products repressed and/or eliminated. 
 
Scheme 6. 
 
  
B) Preparation of β-amino acid model compounds as LEGO-type bricks for foldamer research field. 
The 3-azido-group of compounds 6 and 7 was reduced on two alternative ways: a) hydrogenation in 
H-Cube® with Pd/C; b) transformation via iminophosphorane (Ph3P=N-) under the conditions of 
Staudinger reaction and subsequent hydrolysis (Csordás 2016). Advantages of the use of H-Cube® 
continuous-flow reactor instead of the traditional catalytic hydrogenation are the higher yield and the 
easier separation of the product. 
As mentioned earlier H-AFU-OH derivatives might be significant in peptide-foldamer sciences. The 
appropriate reaction conditions of peptide bond formation with H-AFU-OH are depending both on 
structure and substituents of the β-SAAs. Both N-acylation and N(Me)-amid formation reactions were 
tested on our AFUs (1 and 2) giving either Ac-RibAFU(ip)-NHMe (26) or the xylo epimer Ac-
XylAFU(ip)-NHMe (27) the simplest and smallest models of homo- and hetero-oligomers of peptides 
(Perczel 1991; James 2009; Knapp 2014). Both 3-azido-3-deoxy-furanuronic acids (6 and 7) are 
adequate intermediates for the synthesis of 26 and 27 respectively, standing for a β-amino acids with 
amide bonds at both ends (Scheme 7).  
 
Scheme 7. 
 
N-methyl-carboxamide moiety was formed from both 6 and 7 with conventional amidation methods. 
Reduction of the azido group was carried out in an H-Cube® reactor with Pd/C, resulting in amino 
compound 28 and 29 in excellent yield (85-95%).  
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Interesting to note that by using the Staudinger reaction severe synthetic difficulties were observed, 
namely with the xylo(cis) epimer (30) the failure of the hydrolysis of the unexpectedly stable 
phosphinimine was observed. The rational explanation of the unexpected stability was found in steric 
repulsions and electronic interactions caused by the relative cis position of the vicinal 
triphenylphosphinimino group at C-3 and the substituents of C-4. These structural conditions were 
established by 3D-NMR and X-ray diffraction studies and corroborated by DFT calculations (Csordás 
2016). 
Coupling trans AFU derivatives making new β-peptide derivative (32) 
Foldamer synthesis with sterically hindered amines is a challenge and thus, preliminary reaction in 
optimizing conditions for making short sequences from β-amino acids is a requirement: dimeric, 
tetrameric and hexameric units form some of them were already studied (Chandrasekhar 2004; 
Chandrasekhar 2005; Jagannadh 2006; Pandey 2011; Giri 2012). Here we present the synthesis of N-
terminal ”masked”, C-terminal protected -X-X- type β-dipeptide, by coupling N-methylated 3-amino-
3-deoxy-ribofuranuronamide (28) with the related 3-azido-3-deoxy-ribofuranuronic acid (6, Scheme 
8). The use of compound 6 as a reaction partner is based on the scope of the azido group being indeed 
a robust and uniform ”mask” of the -NH2 functionality, hence, it might play the role of both Fmoc-NH 
and Boc-NH functions widely used in peptide synthesis. 
 
Scheme 8. 
Coupling was carried out in solution under the usual conditions of peptide bond formation and the 
expected β-dipeptide (32) was isolated and purified. Though the yield is poor and needs to be 
improved and optimized, it is important that -tX-tX- can be achieved, thus direct coupling is possible.  
 
Synthesis of N-protected building block for SPPS 
In modern peptide chemistry, the development of synthetic routes for the access of new N-protected 
monomeric amino acids as building block is essential. Thus, we have synthetized Fmoc-protected 
derivatives of -X- by using a continuous-flow hydrogenation reactor and subsequently Fmoc-OSu 
reagent (Scheme 9). At present Boc-protection is unsuitable as both Boc- and 1,2-O-isopropylidene 
group is acid labile. 
Scheme 9. 
The yields of hydrogenation are good (>80%), by using a continuous-flow reactor, a method fast, 
economic, useful and environmentally friendly. The subsequent reaction with Fmoc-OSu was found to 
perform poorer: the N-protected Fmoc-products were of moderate yield (51-49 %). Nevertheless, in 
this way both Fmoc-RibAFU(ip)-OH (33) and its stereoisomer Fmoc-XylAFU(ip)-OH (34) are made, 
the former one synthesized for the first time. Thus, both Fmoc- key intermediates of AFU are now 
available for SPPS. 
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Conclusion 
As we established, the success of the 6(7) stepped synthesis of β-sugar amino acids, as 3-amino-3-
deoxy-pentofuranuronic acids (1 and 2) depends strongly on the efficacy of the transformation of the 
key step of 3-O-sulfonyl ester into the 3-azido-3-deoxy derivative. From D-glucose, the most abundant 
carbohydrate source, both C-3 epimers of the azido-furanuronic acid of both D-ribo and D-xylo 
configuration were obtained within 6(7) consecutive reaction steps. Yields are now optimized, scalable 
and robust reactions are used only. With detailed experimental studies on various fully protected 3-O-
sulfonyl-furanoses we have established optimum conditions forming key intermediates and 
derivatives. As described recently (Pandey 2011; Giri 2012), newly synthesized sugar amino acid 
derivatives including the herein reported Fmoc-X-, key reactions and intermediates of the sterically 
hindered secondary amines were probed to make successfully –Aaa–tX–Aaa– and –Aaa–tX–tX–Aaa– 
type “inserts” for α/β-chimera peptides. Thus, we have shown that both C-3 epimers of 3-azido-3-
deoxy-pentofuranuronic acid, N3-RibAFU(ip)-OH (6) and N3-XylAFU(ip)-OH (7) are suitable 
building blocks to be inserted into β/β-oligopeptides. Making N3-RibAFU(ip)-RibAFU(ip)-NHMe 
(32) is still a challenge due to steric hindrance, a step to be improved (Figure 2).  
 
Figure 2. 
 
These ones and similar compounds are expected to be important intermediates both for academic 
research as well as for manufacturing biocompatible nanomaterials. The herein presented synthetic 
route was selected in line with sustainable or green(er) chemistry (e.g. most chromatography with 
organic solvents eliminated, continuous-flow reactor used for hydrogenation, highly toxic reagents 
replaced), by using the more economic azide intermediates when possible and thus, shortened by two 
reaction steps. All at a lower cost, derivatives now available on multigram scale, products obtained at 
a shorter time. Encompassing most necessary building blocks also tested in key coupling reactions for 
both stereoisomers of X gives “pros and cons” of the route to be selected for further optimization of 
coupling strategies and conditions in making longer oligomers perhaps ligated into polypeptides, 
chimera and foldamers.   
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Experimental section 
Methods 
Reagents, starting materials and solvents were obtained from Sigma-Aldrich, Merck, Reanal and 
VWR. Moisture sensitive solvents either were distilled as standard procedure or dried on molecular 
sieve. Column chromatography was performed on Kieselgel 60 silica gel (0.040-0.063 mm; Merck). 
Reactions were monitored by thin-layer chromatography on Kieselgel 60 F254 (E. Merck). The plates 
were developed by UV-detection (254 nm) and charring with aqueous sulfuric acid solution. Melting 
points were defined with a Boetius microscope apparatus. MS spectra were performed with Bruker 
Esquire 3000+ tandem quadrupole mass spectrometer equipped with an electrospray ion source. FTIR 
spectra were recorded on a Bruker IFS 28 spectrometer by ATR technique. 
1
H-NMR spectra were 
measured with Bruker Avance 250 spectrometer in CDCl3, D2O, DMSO-d6 at room temperature. 
Deuterated solvents were purchased from Sigma-Aldrich.  
 
1,2:5,6-Di-O-isopropylidene-α-D-glucofuranose (3):  
From α-D-glucose (100.0 g; 0.55 mol) with Schmidt’s method (Schmidt 1963). The product 3 formed 
white crystals (79.8 g; 55 %). M. p.: 112-113 °C; lit. m.p. (Schmidt 1963): 110 °C; Rf= 0.74 
(hexane‒EtOAc 1:2). 
1,2:5,6-Di-O-isopropylidene-α-D-allofuranose (13):  
A) From 3 (5.0 g; 0.02 mol) with Austin’s method (Austin 1987), the product 13 formed white crystals 
(3.3 g; 67 %). M.p.: 75-77 C; lit. m.p. (Austin 1987): 77-78 C; Rf = 0.57 (hexane‒EtOAc 1:1). 
B) 1,2:5,6-Di-O-isopropylidene-α-D-glucofuranose (3) (5.0 g; 0.02 mol) was dissolved in DCM (20 
ml) then TEMPO (0.75 g; 4.7 mmol; 0.25 eqv.) and BAIB (2.5 eqv.) were added in several portions. 
The reaction mixture was stirred for 2 days at room temperature. The solution was diluted with DCM 
(100 ml) and washed with saturated Na2S2O3 solution (2x50 ml). The aqueous phase was extracted 
with DCM (5x50 ml). The organic phase was washed with saturated NaHCO3 solution (2x50 ml) and 
brine (2x50 ml). The combined organic extracts were dried (Na2SO4), filtered and concentrated in 
vacuo. The crude ketone was transformed without any isolation and purification. The reduction was 
carried out as in the case of method A). The crude material was purified with column chromatography 
(hexane‒EtOAc 1:1) to give the pure product 13 (2.6 g; 52 %).  
 
Synthesis of 3-O-sulfonate derivatives 
1,2:5,6-Di-O-isopropylidene-3-O-toluenesulfonyl-α-D-glucofuranose (10): 
A) 1,2:5,6-Di-O-isopropylidene-α-D-glucofuranose (3) (3.9 g; 15.0 mmol) was dissolved in dry 
pyridine (15 ml) and p-toluenesulfonyl chloride (5.7; 29.9 mmol) was added to the solution with 
stirring at room temperature. The suspension was stirred for 1 day and allowed to stand for overnight 
at 0 °C. The reaction mixture was poured into ice ‒ water, the precipitate was filtered, washed with 
cold water. The cream-colored crude material was recrystallized from ethanol (95 %) to give white 
crystalline product 10 (5.1 g; 83 %). M.p.: 125-127 C; lit. m.p. (Whistler 1972): 122-123 °C; Rf = 
0.80 (hexane‒EtOAc 2:1). 
B) From 3 (19.5 g; 75.0 mmol) the yield was 81 % (25.1 g). 
1,2:5,6-Di-O-isopropylidene-3-O-toluenesulfonyl-α-D-allofuranose (16): 
A) From 1,2:5,6-di-O-isopropylidene-α-D-allofuranose (13) (10.0 g; 38.0 mmol) the reaction was 
carried out with the same method as the formation of 10. After recrystallization of the crude product 
from ethanol (90 %) the product 16 was got as white crystals (6.3 g; 63 %). M.p.: 118-120 C; lit. m.p. 
(Theoneste 2009): 116-118 °C; Rf = 0.64 (hexane‒EtOAc 1:1). 
B) From 13 (19.5 g; 75.0 mmol) the yield was 66 % (20.5 g). 
1,2:5,6-Di-O-isopropylidene-3-O-methanesulfonyl-α-D-glucofuranose (9): 
1,2:5,6-Di-O-isopropylidene-α-D-glucofuranose (3) (2.0 g; 7.7 mmol) was dissolved in dry pyridine (6 
ml), cooled at 0 °C and methanesulfonyl chloride (0.8 ml) was dropped to the solution. The reaction 
mixture was allowed to stand for 2 days at 0 °C. After the solution was poured into ice ‒ water, the 
solid crude product was filtered, washed with cold water and recrystallized from methanol (50 %) to 
give white crystalline product 9 (1.8 g; 68 %). M.p.: 83-84 °C; lit. m.p. (Helferich 1939): 83-84 °C; Rf 
= 0.44 (hexane‒EtOAc 2:1). 
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1,2:5,6-Di-O-isopropylidene-3-O-methanesulfonyl-α-D-allofuranose (15): 
From 1,2:5,6-di-O-isopropylidene-α-D-allofuranose (13) (0.50 g; 1.9 mmol) the reaction was carried 
out with the same method as the formation of 9. Recrystallization of the crude product from ethanol 
gave white crystalline product 15 (0.32 g; 50 %). M.p.: 133-136 C; lit. m.p. (Meyer zu Reckendorf 
1968): 130-133 °C; Rf = 0.44 (hexane‒EtOAc 1:1). 
1,2:5,6-Di-O-isopropylidene-3-O-trifluoromethanesulfonyl-α-D-glucofuranose (8): 
1,2:5,6-Di-O-isopropylidene-α-D-glucofuranose (3) (3.0 g; 0.01 mol) was dissolved in 
dichloromethane (30 ml) containing pyridine (2.8 ml). The reaction mixture was cooled at -10 C and 
under N2-atmosphere trifluoromethansulfonic anhydride (2.9 ml) was dropped to the solution. The 
reaction mixture was stirred for 2 h. After the solution was poured into ice ‒ water, the aqueous phase 
was extracted with dichloromethane. The organic phase was dried (Na2SO4), filtered and concentrated 
in vacuo. The white crystalline product 8 crystallized from n-hexane (4.1 g; 90 %). M.p.: 76-77 °C; lit. 
m.p.
 
(Hall 1976): 70 °C; Rf = 0.61 (hexane‒EtOAc 1:2). 
1,2:5,6-Di-O-isopropylidene-3-O-trifluoromethanesulfonyl-α-D-allofuranose (14):  
From 1,2:5,6-di-O-isopropylidene-α-D-allofuranose (13) (0.50 g; 2.0 mmol) the reaction was carried 
out with the same method as the formation of 8. The product 14 was pale yellow syrup (0.62 g; 83 %). 
Rf = 0.38 (hexane‒EtOAc 4:1). 
1,2:5,6-Di-O-isopropylidene-3-O-(N-imidazole-1-sulfonyl)-α-D-glucofuranose (11): 
A) 1,2:5,6-Di-O-isopropylidene-α-D-glucofuranose (3) (1.0 g; 4.0 mmol) was dissolved in DMF (20 
ml), cooled at 0 °C and under N2-atmosphere NaH (0.14 g; 6.0 mmol) was added to the solution. The 
suspension was stirred for 30 min and cooled to -35 - 
-40 °C. After N’,N-sulfonyl-diimidazole (1.2 g; 
6.0 mmol) in DMF (12 ml) was dropped to the reaction mixture and stirred for 30 min again at -40 °C. 
MeOH was added (0.8 ml) to the solution and stirred for 30 min at -40 °C. The solution was poured 
into ice ‒ water (200 ml). The precipitate was filtered, washed with cold water to get the white 
crystalline product 11 (1.2 g; 80 %). M.p.: 97-98 °C; lit. m.p. (Vatéle 1996): 98-99 °C; Rf = 0.70 
(EtOAc‒hexane 1:1). 
B) From 3 (25.0 g; 96.0 mmol) the yield was 84 % (31.5 g). 
1,2:5,6-di-O-isopropylidene-3-O-(N-imidazole-1-sulfonyl)-α-D-allofuranose (17):  
A) From 1,2:5,6-di-O-isopropylidene-α-D-allofuranose (13) (1.0 g; 4.0 mmol) the reaction was carried 
out with the same method as the formation of 11, but after the solution was poured into ice ‒ water,  
the aqueous phase was extracted with diethyl ether (4x60 ml). The combined organic extracts were 
washed with water (4x30 ml) to pH 7. The organic phase was dried (MgSO4), filtered and 
concentrated in vacuo to give colourless oil (1.4 g; 87 %). Rf = 0.40 (EtOAc‒hexane 1:1); ESI-MS: 
391.2 [M+H]
+
, calculated: 390.4 m/z. 
B) From 13 (25.0 g; 96.0 mmol) the yield was 80 % (30.0 g). 
 
Sulfonate ester→azide SN-reaction 
1,2:5,6-di-O-isopropylidene-3-azido-3-deoxy-α-D-allofuranose (4): 
A) 1,2:5,6-Di-O-isopropylidene-3-O-toluenesulfonyl-α-D-glucofuranose (10) (1.2 g; 3.0 mmol) was 
dissolved in DMSO (33 ml). Sodium azide (1.2 g; 18.0 mmol; 6 eqv.) was added to the solution and 
stirred at 140-145 C for 54 h. The reaction was followed by TLC (hexane-EtOAc 3.5:1). The reaction 
mixture was poured into ice ‒ water (250 ml), extracted with petroleum ether (6x15 ml) and with 
ethyl-acetate (2x15 ml). The combined organic extracts were washed with brine (1x20 ml), dried 
(Na2SO4), filtered and concentrated in vacuo to afford the crude product, which was the mixture of 4 
and the by-product 12. The crude product was purified by column chromatography (hexane-EtOAc 
4:1, 3:1). The product 4 was colourless oil (0.26 g; 41 %). Rf = 0.53 (hexane‒EtOAc 3:1); FTIR-ATR: 
νmax: 2106 (ν N3) cm
-1
. The by-product 12 formed white crystals (0.02 g; 3 %). M.p.: 49-50 °C; lit. m.p. 
(Whistler 1972): 51 °C; Rf = 0.75 (hexane‒EtOAc 3:1); FTIR-ATR: νmax: 1672 (ν C=C) cm
-1
.  
B) From 10 (25.1 g; 60.6 mmol) the yield was 45 % (7.8 g) for 4 and 8 % (1.2 g) for 12. 
C) From 10 (0.41 g; 1.0 mmol) the reaction occurred analogously to method A), with sodium azide (4 
eqv.) and catalytic amount of tetra-N-butylammonium hydrogensulfate (0.006 eqv.) was added to the 
solution. The reaction mixture was stirred at 140-145 C for 33 h. The product 4 was colourless oil 
(0.09 g; 44 %), the by-product 12 formed white crystals (0.01 g; 7 %). Spectral and chromatographic 
data of the products are in agreement with the data of the products by A). 
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D) From 10 (24.1 g; 58.1 mmol) the reaction occurred analogously to method B), with tetra-N-
butylammonium chloride (0.006 eqv.) catalyst. The reaction mixture was stirred at 130-135 C for 73 
h. The crude product was purified by column chromatography (hexane-acetone 14:1). The product 4 
was colourless oil (5.4 g; 33 %), the by-product 12 formed white crystals (1.5 g; 11 %). Spectral and 
chromatographic data of the products are in agreement with the data of the products by A). 
E) From 10 (25.0 g; 60.3 mmol) the reaction occurred analogously to method A), in DMSO – H2O 
96:4. The crude product was purified by flash chromatography (hexane-acetone 14:1). The yield for 4 
was 37 % (6.3 g) and for 12 was 7 % (1.1 g). Spectral and chromatographic data of the products are in 
agreement with the data of the products by A). 
F) 1,2:5,6-Di-O-isopropylidene-3-O-methanesulfonyl-α-D-glucofuranose (9) (0.34 g; 1.0 mmol) was 
dissolved in DMSO (8 ml). Sodium azide (0.59 g; 9.0 mmol; 9 eqv.) was added to the solution and 
stirred at 140-145 C for 181 h. The processing of the reaction mixture was analogous to the above. 
The crude product was homogeneous containing only the main product 4, so further purification was 
not necessary. The product 4 was colourless oil (0.12 g; 54 %). Spectral and chromatographic data of 
the product is in agreement with the data of the product by A). 
G) 1,2:5,6-Di-O-isopropylidene-3-O-trifluoromethanesulfonyl-α-D-glucofuranose (8) (0.56 g; 1.4 
mmol) was dissolved in DMF (25.5 ml). Sodium azide (0.19 g; 2.9 mmol; 2 eqv.) and catalytic amount 
of tetra-N-butylammonium hydrogensulfate (0.002 g; 0.006 mmol) were added to the solution and 
stirred at 50 C for 3 h and at room temperature for 13 h. The reaction was followed by TLC (hexane-
EtOAc 3.5:1). The reaction mixture was concentrated in vacuo, the residue was dissolved in EtOAc 
(20 ml) and extracted with water (2x5 ml). The aqueous phase was extracted with EtOAc (3x3 ml). 
The combined organic extracts were dried (MgSO4), filtered and concentrated in vacuo to afford the 
crude product, which was the mixture of 4 and 12. The crude product was purified by flash 
chromatography (hexane-EtOAc 3.5:1, 3.2:1, 2.5:1). The yield for 4 was 59 % (0.18 g) and for 12 was 
36 % (0.09 g). Spectral and chromatographic data of the products are in agreement with the data of the 
products by A). 
H) 1,2:5,6-Di-O-isopropylidene-3-O-(N-imidazole-1-sulfonyl)-α-D-glucofuranose (11) (1.1 g; 2.8 
mmol) was dissolved in toluene (33 ml). Tetra-N-butylammonium bromide (2.7 g; 8.4 mmol; 3 eqv.) 
and NaN3 (0.55 g; 8.5 mmol; 3 eqv) were added to the solution and stirred for 30 min at room 
temperature. After the reaction mixture was refluxed for 10 h at 80 °C. The reaction was followed by 
TLC (EtOAc - hexane 1:1). After the reaction was complete, KMnO4 solution (0.45 g; 1 eqv.) was 
added to the reaction mixture and stirred for 5 h. The organic phase, which contained only the main 
product 4 was separated and washed with water (2x10 ml). The combined organic extracts were dried 
(Na2SO4), filtered and concentrated in vacuo to afford the product 4 as colourless oil (0.42 g; 52 %). 
Spectral and chromatographic data of the product are in agreement with the data of the product by A). 
I) From 11 (31.5 g; 80.8 mmol) the yield was 62 % (14.3 g). 
J) From 11 (0.3 g; 0.77 mmol) the reaction was analogous with method H), but the solvent was DMSO 
instead of toluene and the crude product, which was the mixture 4 and 12 was purified by column 
chromatography (hexane-acetone 14:1). The yield was 72 % (0.16 g) for 4 and 20 % (0.04 g) for 12. 
1,2:5,6-di-O-isopropylidene-3-azido-3-deoxy-α-D-glucofuranose (5): 
A) 1,2:5,6-Di-O-isopropylidene-3-O-(N-imidazole-1-sulfonyl)-α-D-allofuranose (17) (1.4 g; 3.5 
mmol) was dissolved in toluene (40 ml). Tetra-N-butylammonium bromide (3.3 g; 0.01 mol; 3 eqv) 
and NaN3 (0.67 g; 0.01 mol; 3 eqv) were added to the solution and stirred for 30 min at room 
temperature. After the reaction mixture was refluxed for 8 h between 80-90 °C. The reaction was 
followed by TLC (EtOAc-hexane 1:1). The precipitated NaBr was filtered. The organic phase was 
washed with water (5x10 ml), with saturated NaHCO3 solution (2x10 ml) and brine (1x20 ml), dried 
(MgSO4), filtered and concentrated in vacuo to afford the product 5 as colourless oil (0.89 g; 90 %). 
Rf = 0.83 (EtOAc‒hexane 1:1); FTIR-ATR: νmax: 2111 (ν N3) cm
-1
. 
B) From 17 (30.0 g; 76.9 mmol) the yield was 88 % (21.9 g). 
C) 1,2:5,6-Di-O-isopropylidene-3-O-toluenesulfonyl-α-D-allofuranose (16) (20.0 g; 0.05 mol) was 
dissolved in DMSO (333 ml). Sodium azide (15.6 g; 0.24 mol; 5 eqv) and catalytic amount of tetra-N-
butylammonium hydrogensulfate (0.09 g; 0.27 mmol) were added to the solution and refluxed at 135 
C for 52 h. The reaction was followed by TLC (hexane-EtOAc 3.5:1), cooled at room temperature 
and streamed to ice ‒ water (3 l). The solution was extracted with petroleum ether (8x200 ml) and the 
combined organic extracts were washed with brine (3x200 ml), dried (MgSO4), filtered and 
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concentrated in vacuo to afford a gold oil. The crude product was purified by column chromatography 
(hexane-EtOAc 3.5:1) to give a light yellow oil (10.2 g; 74 %). Spectral and chromatographic data of 
the product are in agreement with the data of the product by A). 
D) From 1,2:5,6-di-O-isopropylidene-3-O-trifluoromethanesulfonyl-α-D-allofuranose (14) the reaction 
was analogous to the reaction of 16. The reaction mixture was stirred at 120 °C for 20 h. The yield was 
53 % for 5. 
E) From 1,2:5,6-di-O-isopropylidene-3-O-methanesulfonyl-α-D-allofuranose (15) the reaction was 
analogous to the reaction of 16. The reaction mixture was stirred at 120 °C for 180 h. The yield was 87 
% for 5. 
1,2-O-isopropylidene-3-azido-3-deoxy-α-D-allofuranose (19): 
1,2-O-isopropylidene-3-O-toluenesulfonyl-α-D-glucofuranose (18) (0.50 g; 1.3 mmol) was dissolved 
in DMSO (1.8 ml). Sodium azide (0.35 g; 5.2 mmol; 4 eqv.) in DMSO (9.4 ml) was dropped to the 
solution and stirred at 135 C for 29 h. The reaction mixture was poured into ice ‒ water (15.0 ml), 
extracted with ethyl-acetate (7x3 ml) and the combined organic extracts were washed brine (1x5 ml), 
dried (Na2SO4), filtered and concentrated in vacuo to afford the crude product, which was the mixture 
of the main product 19 and the elimination by-product 20. The crude product was purified by column 
chromatography (EtOAc-hexane 2:1). The product 19 formed white crystals (0.11 g; 36 %). M.p.: 76-
78 C; lit. m.p. (Gomtsyan 1992): 75-76 °C; Rf = 0.54 (EtOAc); FTIR-ATR: νmax: 3500 and 3358 (ν 
OH), 2100 (ν N3) cm
-1
. The by-product 20 is yellow oil (0.006 g; 2 %). 
1,2-O-isopropylidene-3-azido-3-deoxy-α-D-glucofuranose (25): 
1,2-O-isopropylidene-3-O-toluenesulfonyl-α-D-allofuranose (23) (0.50 g; 1.3 mmol) was dissolved in 
DMSO (1.8 ml). Sodium azide (0.52 g; 7.9 mmol; 6 eqv.) in DMSO (9.4 ml) was dropped to the 
solution and stirred at 135 C for 28 h. The reaction mixture was poured into ice ‒ water (15.0 ml), 
extracted with ethyl-acetate (6x3 ml) and the combined organic extracts were washed with brine (1x5 
ml), dried (Na2SO4), filtered and concentrated in vacuo to afforded the product 25 as white crystals 
(0.09 g; 28 %). M.p.: 82-85 C; lit. m.p. (Kovář 1969): 83-84 °C; Rf = 0.35 (hexane‒EtOAc 1:1); 
FTIR-ATR: νmax: 3404 (ν OH), 2102 (ν N3) cm
-1
. 
1
H NMR (CD3OD, 250 MHz) δ = 5.80 (d, J= 3.62 
Hz, 1H), 4.66 (d, J= 3.63 Hz, 1H), 4.14 (d, J= 3.06 Hz, 1H), 3.72 (m, 2H), 3.54 (m, 1H), 3.28 (d, J= 
1.52 Hz, 1H), 1.43 and 1.28 (s, 6H) ppm.  
Methyl 3-deoxy-l,2-O-isopropylidene-D-glycero-pent-3-enofuranuronate (22):  
A) 1,2-O-isopropylidene-3-O-toluenesulfonyl-α-D-xylofuranuronic acid methyl ester (21) (0.11 g; 
0.28 mmol) was dissolved in DMSO (0.4 ml). Sodium azide (0.07 g; 1.1 mmol; 4 eqv.) in DMSO (2.1 
ml) was dropped to the solution and stirred at 80 C for 5 h. The reaction mixture was poured into ice 
‒ water (10 ml) and extracted with ethyl-acetate (4x3 ml) and the combined organic extracts were 
washed with brine (1x5 ml), dried (Na2SO4), filtered and concentrated in vacuo to afford the product 
22 as yellow oil (0.09 g; 90 %). Rf = 0.70 (EtOAc‒hexane 1:2); FTIR-ATR: νmax: 1735 ( C=O); 1627 
( C=C) cm-1. 1H NMR (CDCl3, 250 MHz) δ = 6.11 (d, J= 5.35 Hz, 1H), 6.03 (d, J= 1.93 Hz, 1H), 
5.31 (dd, J= 2.34 Hz, J= 4.96 Hz, 1H), 3.78 (s, 3H), 1.39 (s, 6H) ppm. 
B) From 1,2-O-isopropylidene-3-O-toluenesulfonyl-α-D-ribofuranuronic acid methyl ester (24) (0.10 
g; 0.26 mmol) the reaction was carried out as in the case of method A). The product 22 was yellow oil 
(0.05 g; 92 %). Spectral and chromatographic data of the product are in agreement with the data of the 
product by A). 
 
Removal of OH-5 and OH-6 isopropylidene protecting group 
1,2-O-isopropylidene-3-azido-3-deoxy-α-D-allofuranose (19):  
A) 1,2:5,6-di-O-isopropylidene-3-azido-3-deoxy-α-D-allofuranose (4) (2.7 g; 9.6 mmol) was dissolved 
in acetic acid (44 ml, 75 %). The solution was stirred at room temperature for 2 days and concentrated 
in vacuo. After evaporation of the organic solvents, crude product was purify with column 
chromatography (EtOAc-hexane 2:1) afforded white crystals (2.2 g; 92 %). Spectral and 
chromatographic data of the product are in agreement with the data of the product above. 
B) From 4 (14.0 g; 49.1 mmol) the yield was 90 % (10.8 g). 
1,2-O-isopropylidene-3-azido-3-deoxy-α-D-glucofuranose (25):  
A) From 1,2:5,6-di-O-isopropylidene-3-azido-3-deoxy-α-D-glucofuranose (5) (10.0 g; 35.0 mmol) the 
reaction was carried out with the same method as the formation of 19. After crystallization of the 
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crude product from ethyl acetate – n-hexane 1:1 the pure product 25 was got in the form of white 
crystals (5.4 g; 67 %). Spectral and chromatographic data of the product are in agreement with the data 
of the product above. 
B) From 5 (21.0 g; 73.7 mmol) the yield was 65 % (11.7 g). 
1,2-O-isopropylidene-3-O-toluenesulfonyl-α-D-glucofuranose (18): 
From 1,2:5,6-di-O-isopropylidene-3-O-toluenesulfonyl-α-D-glucofuranose (10) (6.0 g; 14.5 mmol) the 
reaction was carried out with the same method as the formation of 19. After purification of the crude 
product with column chromatography (EtOAc-hexane 2:1) the pure product 18 was obtained as 
colourless oil (5.2 g; 95 %); Rf = 0.62 (EtOAc–hexane 2:1). FTIR-ATR: νmax: 3520 ( OH) cm
-1
; ESI-
MS: 392.3 [M+NH4]
+
, calculated: 374.41 m/z.
 1
H NMR (DMSO-d6, 250 MHz) δ = 7.83 (d, J= 8.31 
Hz, 2H), 7.47 (d, J= 8.10 Hz, 2H), 5.93 (d, J= 3.83 Hz, 1H), 4.68 (dd, J= 3.32 Hz, J=7.61 Hz, 2H), 
4.62 (d, J= 6.18 Hz, 1H), 4.54 (t, J= 5.44 Hz, 1H), 4.02 (dd, J= 2.71 Hz, J= 9.01 Hz, 1H), 3.48 (m, 
1H),  2.42 (s, 3H), 1.37 (s, 3H), 1.23 (s, 3H) ppm. 
1,2-O-isopropylidene-3-O-toluenesulfonyl-α-D-allofuranose (23):  
From 1,2:5,6-di-O-isopropylidene-3-O-toluenesulfonyl-α-D-allofuranose (16) (2.0 g; 4.8 mmol) the 
reaction was carried out with the same method as the formation of 19. After purification of the crude 
product with column chromatography (EtOAc-hexane 2:1) the pure product 23 was pale yellow oil 
(1.7 g; 93 %). Rf = 0.57 (EtOAc–hexane 2:1); FTIR-ATR: νmax: 3534 ( OH) cm
-1
; ESI-MS: 392.3 
[M+NH4
+
]
+
, calculated: 374.4 m/z.
 1
H NMR (DMSO-d6, 250 MHz) δ = 7.83 (d, J= 8.22 Hz, 2H), 7.47 
(d, J= 8.18 Hz, 2H), 5.93 (d, J = 3.68 Hz, 1H), 4.67 (dd, J = 3.17 Hz, J= 10.09 Hz, 2H), 4.59 (d, J = 
6.01 Hz, 1H), 4.52 (t, J = 5.16 Hz, 1H), 4.03 (dd, J= 2.53 Hz, J= 8.98 Hz, 1H), 3.48 (m, 1H), 2.42 (s, 
3H),  1.37 (s, 3H), 1.23 (s, 3H) ppm. 
 
Formation of COOH functional group 
1,2-O-isopropylidene-3-azido-3-deoxy-α-D-ribofuranuronic acid (6): 
A) 1,2-O-isopropylidene-3-azido-3-deoxy--α-D-allofuranose (19) (0.89 g; 3.7 mmol) was dissolved in 
MeOH – water 6:4 (10.5 ml) and cooled at 0 C. Sodium periodate (0.88 g; 4.1 mmol) was dissolved 
in water (6.3 ml) and added to the solution of the starting material. The reaction mixture was stirred 
for a day at room temperature. The inorganic salts were precipitated by addition of methanol (15 ml), 
were filtered off and washed several times with MeOH. The solvent was removed and the crude 
product was reacted without purification. The aldehyde-derivative was dissolved in acetic acid (18 ml, 
50 %). Potassium permanganate (0.83 g; 5.2 mmol) was dissolved in water (16 ml) and added to the 
solution. The reaction mixture was stirred for 12 h at room temperature, then was allowed to stand at 0 
°C for 2 days. The reaction mixture was filtered, excess KMnO4 was removed with sodium sulphite. 
The solution was adjusted to pH 2-3 with 2M HCl and extracted with ethyl acetate (6x10 ml). The 
aqueous phase was saturated with sodium chloride and extracted with ethyl acetate (1x10 ml). The 
combined organic extracts were extracted with saturated sodium chloride solution (2x15 ml). The 
organic phase was dried (MgSO4) and concentrated in vacuo to afford the crude product. After 
crystallization of the crude product from ethyl acetate – n-hexane afforded white crystals (0.74 g; 88 % 
for 2 steps). M.p.: 110-112 C; lit. m.p. (Kulinkovich 1983): 107-108 °C; Rf = 0.44 
(chloroform‒methanol 3:2). FTIR-ATR: νmax : 3500-2400 (ν COOH), 2107 (ν N3), 1736 (ν C=O) cm
-1
; 
ESI-MS: 228.2 [M-H]
-
, calculated: 229.2 m/z; 
1
H NMR (CDCl3, 250 MHz) δ = 7.92 (br s, 1H), 5.87 
(d, J= 3.1 Hz, 1H), 4.72 (br m, J= 4.2 Hz, 1H), 4.55 (d, J= 9.5 Hz, 1H), 3.68 (dd, J= 4.2 Hz, J= 9.5 Hz, 
1H), 1.53 (s, 3H), 1.32 (s, 3H) ppm. 
B) From 19 (10.0 g; 40.8 mmol) the yield was 80 % (7.5 g) for the 2 steps. 
1,2-O-isopropylidene-3-azido-3-deoxy-α-D-xylofuranuronic acid (7): 
A) From 1,2-O-isopropylidene-3-azido-3-deoxy--α-D-glucofuranose (25) (5.0 g; 0.02 mol) the 
reaction was carried out with the same method as the formation of 6. In this case the reaction mixture 
was extracted with chloroform (1x) and dichloromethane (5x). The product 7 was pale yellow oil (3.8 
g; 82 % for 2 steps). Rf = 0.11 (hexane‒EtOAc 1:4); FTIR-ATR: νmax: 3462 (ν OH), 2108 (ν N3), 1735 
(ν C=O) cm-1; ESI-MS: 228.2 [M-H]-, calculated: 229.2 m/z. 
B) From 25 (10.0 g; 40.8 mmol) the yield was 78 % (7.3 g) for the 2 steps. 
1,2-O-isopropylidene-3-O-toluenesulfonyl-α-D-xylofuranuronic acid (35): 
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From 1,2-O-isopropylidene-3-O-toluenesulfonyl-α-D-glucofuranose (18) (1.0 g; 2.7 mmol) the 
reaction was carried out with the same method as the formation of 6. The product 35 was colourless 
oil (0.26 g; 27 % for 2 steps). Rf = 0.70 (toluene‒EtOAc‒EtOH‒AcOH 4:2:2:1). FTIR-ATR: νmax: 
3500-2400 (ν COOH), 1756 (ν C=O); ESI-MS: 376.3 [M+NH4]
+
, calculated: 358.37 m/z; 
1
H NMR 
(CDCl3, 250 MHz) δ = 7.75 (d, J= 8.36 Hz, 2H), 7.36 (d, J= 8.08 Hz, 2H), 6.12 (d, J= 3.42 Hz, 1H), 
5.02 (d, J= 3.35 Hz, 1H), 4.93 (d, J= 3.43 Hz, 1H), 4.82 (d, J = 3.36 Hz, 1H), 2.45 (s, 3H), 1.49 (s, 
3H), 1.34 (s, 3H) ppm.  
1,2-O-isopropylidene-3-O-toluenesulfonyl-α-D-ribofuranuronic acid (36): 
From 1,2-O-isopropylidene-3-O-toluenesulfonyl-α-D-allofuranose (23) (1.0 g; 2.7 mmol) the reaction 
was carried out with the same method as the formation of 6. The product 36 was pale yellow (0.16 g; 
16 % for 2 steps). Rf = 0.73 (toluene‒EtOAc‒EtOH‒AcOH 4:2:2:1). FTIR-ATR: νmax: 3500-2400 (ν 
COOH), 1747 (C=O) cm
-1
; ESI-MS: 376.3 [M+NH4]
+
, calculated: 358.37 m/z; 
1
H NMR (DMSO-d6, 
250 MHz) δ = 7.77 (d, J= 8.25 Hz, 2H), 7.48 (d, J= 8.16 Hz, 2H), 6.03 (d, J= 3.68 Hz, 1H), 4.87 (d, J= 
3.27 Hz, 1H), 4.79 (d, J= 3.32 Hz, 1H), 4.69 (d, J = 3.72 Hz, 1H), 2.43 (s, 3H), 1.40 (s, 3H), 1.24 (s, 
3H) ppm.  
 
Formation of NH2 from N3-group 
1,2-O-isopropylidene-3-amino-3-deoxy--D-ribofuranuronic acid (1): 
1,2-O-isopropylidene-3-azido-3-deoxy-α-D-ribofuranuronic acid (6) (0.26 g; 1.1 mmol) was dissolved 
in methanol (31.8 ml, c= 35 mmol/l) and reduced with H2 on 10 % Pd/C by H-Cube (parameters: 60 
°C, 10 bar, 0.3 ml/min). After the reaction, the solution was concentrated in vacuo to give the product 
1 as pale yellow oil (0.19 g; 84 %). Rf = 0.51 (chloroform‒methanol 3:2). FTIR-ATR: νmax : 3170 (ν 
NH3
+
), 2750-2460 and 2170-1900 diffuse (ν NH3
+
), 1605 (ν COO-) cm-1. ESI-MS: 204.1 [M+H]+, 
calculated: 203.19 m/z. 
1
H NMR (D2O, 250 MHz) δ = 6.04 (d, J= 3.7 Hz, 1H), 4.97 (t, J= 4.60 Hz, 
1H), 4.43 (d, J= 10.10 Hz, 1H), 3.68 (dd, J= 4.60 Hz, J= 10.10 Hz, 1H), 1.58 (s, 3H), 1.39 (s, 3H) 
ppm. 
1,2-O-isopropylidene-3-amino-3-deoxy--D-xylofuranuronic acid (2):  
From 1,2-O-isopropylidene-3-azido-3-deoxy-α-D-xylofuranuronic acid (7) (0.20 g; 0.87 mmol) the 
reaction was carried out with the same method as the formation of 1. The product was pale yellow oil 
(0.14 g; 80 %). Rf = 0.50 (chloroform‒methanol 3:2); FTIR-ATR: νmax: 2977, 2465 ( COOH), 1637 
( COO
-
), 1560, 1377 (asCOO
-
,
 s CH3) cm
-1
; ESI-MS: 204.2 [M+H]
+
, calculated: 203.19 m/z. 
1
H 
NMR (D2O, 250 MHz) δ = 5.97 (d, J= 3.83 Hz, 1H), 4.79 (d, J= 3.85 Hz, 1H), 4.65 (overlapped by the 
signal of D2O, 1H), 3.86 (d, J= 3.95 Hz, 1H), 1.39 and 1.21 (s, 6H) ppm.  
 
Formation of ester derivatives 
1,2-O-isopropylidene-3-O-toluenesulfonyl-α-D-xylofuranuronic acid methyl ester (21):  
1,2-O-isopropylidene-3-O-toluenesulfonyl-α-D-xylofuranuronic acid (35) (0.20 g; 0.56 mmol) was 
dissolved in dichloromethane (10 ml) and cooled to 0 °C. The cold diazomethane / diethyl ether 
solution (15 ml) was dropped to the reaction mixture, while the yellow colour was remained for 20 
min. The rest of the diazomethane was removed with air and the solution was concentrated in vacuo to 
get the product 21 as pale yellow oil (0.20 g; 96 %). Rf = 0.66 (EtOAc‒hexane 1:1); FTIR-ATR: νmax: 
1767 (ν C=O) cm-1. ESI-MS: 390.3 [M+NH4]
+
, calculated: 372.40 m/z;
 1
H NMR (CDCl3, 250 MHz) δ 
= 7.77 (d, J= 8.32 Hz, 2H), 7.37 (d, J= 8.21 Hz, 2H), 6.07 (d, J= 3.50 Hz, 1H), 5.13 (d, J= 3.26 Hz, 
1H), 4.84 (d, J= 3.31 Hz, 1H), 4.77 (d, J= 3.50 Hz, 1H), 3.58 (s, 3H), 2.46 (s, 3H), 1.48 (s, 3H), 1.32 
(s, 3H) ppm.  
1,2-O-isopropylidene-3-O-toluenesulfonyl-α-D-ribofuranuronic acid methyl ester (24): 
From 1,2-O-isopropylidene-3-O-toluenesulfonyl-α-D-ribofuranuronic acid (36) (0.12 g; 0.33 mmol) 
the reaction was carried out with the same method as the formation of 21. The product 24 was pale 
yellow oil (0.12 g; 96 %). Rf = 0.69 (EtOAc‒hexane 1:1); FTIR-ATR: νmax: 1766 (ν C=O) cm
-1
. ESI-
MS: 390.32 [M+NH4]
+
, calculated: 372.40 m/z;
 1
H NMR (CDCl3, 250 MHz) δ = 7.70 (d, J= 8.35 Hz, 
2H), 7.30 (d, J= 8.09 Hz, 2H), 6.00 (d, J= 3.53 Hz, 1H), 5.06 (d, J= 3.32 Hz, 1H), 4.77 (d, J= 3.33 Hz, 
1H), 4.71 (d, J= 3.54 Hz, 1H), 3.51 (s, 3H), 2.40 (s, 3H), 1.41 (s, 3H), 1.25 (s, 3H) ppm.  
1,2-O-isopropylidene-3-azido-3-deoxy--D-ribofuranuronic acid methyl ester (37): 
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From 1,2-O-isopropylidene-3-azido-3-deoxy--D-ribofuranuronic acid (6) (0.40 g; 1.7 mmol) the 
reaction was carried out with the same method as the formation of 21.  The crude product was purified 
by column chromatography (hexane-EtOAc 1:2). The product (37) was colourless yellow oil (0.34 g; 
80 %). Rf = 0.90 (hexane-EtOAc 1:2.5); FTIR-ATR: νmax: 2115 (ν N3), 1745 (ν C=O) cm
-1
. ESI-MS: 
261.2 [M+NH4]
+
, calculated: 243.2 m/z;
 1
H NMR (CDCl3, 250 MHz) δ = 5.86 (d, J= 3.43 Hz, 1H), 
4.69 (t, J= 3.97 Hz, 1H), 4.50 (d, J= 9.58 Hz, 1H), 3.79 (s, 3H), 3.64 (dd, J= 4.50 Hz, J= 9.56 Hz,  
1H), 1.52 (s, 3H), 1.31 (s, 3H) ppm.  
1,2-O-isopropylidene-3-azido-3-deoxy-α-D-ribofuranuronic acid isopropyl ester (38): 
1,2-O-isopropylidene-3-azido-3-deoxy-α-D-ribofuranuronic acid (6) (0.50 g; 2.2 mmol) was dissolved 
in CH3CN (4.2 ml) and cooled at 0 °C. Oxalyl-chloride (0.34 ml) and dry DMF (0.16 ml) were 
dropped to the solution and stirred for 5 hours at room temperature. The solvent was removed, the 
residue was dissolved in CHCl3 (1.7 ml) and cooled 0 °C. 2-PrOH (6.0 ml) was dropped slowly to the 
solution and stirred for 45 minutes. The reaction mixture was poured onto iced water and extracted 
with DCM (5x8 ml). The organic phase was dried (Na2SO4) and concentrated. The crude product was 
isolated and purified by column chromatography (hexane-EtOAc 1:2) to give colourless oil (0.32 g; 54 
%). FTIR-ATR: νmax: 2106 ( N3), 1738 ( C=O), 1369 (as C-CO-O) cm
-1
. 
1
H NMR (CDCl3, 250 
MHz): δ 5.84 (d, J= 3.49 Hz, 1H), 5.10 (sept, J= 6.31 Hz, J=6.33 Hz, J=6.33 Hz, 1H), 4.67 (m, 1H), 
4.45 (d, J= 9.60 Hz, 1H), 3.63 (dd, J= 4.54 Hz, J= 9.56 Hz, 1H), 1.52 and 1.30 (s, 6H), 1.27 and 1.23 
(d, 6H) ppm. 
 
Synthesis of uronamide derivatives  
N-methyl-1,2-O-isopropylidene-3-azido-3-deoxy-α-D-ribofuranuronamide (31): 
A) 1,2-O-isopropylidene-3-azido-3-deoxy-α-D-ribofuranuronic acid (6) (0.50 g; 2.2 mmol) was 
dissolved in dry THF (4.2 ml) and cooled to 0 °C. Oxalyl-chloride (0.34 ml) and dry DMF (0.16 ml) 
were dropped to the solution and stirred for 5 h at room temperature. The solvent was removed, the 
residue was dissolved in DCM (1.7 ml) and cooled 0 °C. Slowly 2M MeNH2 / THF solution (6.0 ml) 
was dropped to the solution and it was stirred for 45 min. The reaction mixture was poured into ice ‒ 
water and extracted with DCM (5x8 ml). The organic phase was dried (Na2SO4) and concentrated in 
vacuo. The crude product was isolated and purified by column chromatography (hexane-EtOAc 1:2) to 
give white crystals (0.14 g; 27 %). M.p.: 170-173 °C; Rf = 0.34 (EtOAc‒hexane 2:1); FTIR-ATR: νmax: 
3368 ( NH), 2110 (ν N3), 1652 (amide I,  C=O and  C-N), 1538 (amide II) cm
-1
; ESI-MS: 243.2 
[M+H]
+
, calculated: 242.2 m/z; 
1
H NMR (CDCl3, 250 MHz) δ = 6.49 (broad m, 1H), 5.82 (d, J= 3.4 
Hz, 1H), 4.69 (t, J= 4.5 Hz, 1H), 4.45 (d, J= 9.5 Hz, 1H), 3.64 (dd, J= 4.5 Hz, J=9.5 Hz, 1H), 2.83 (d, 
J= 5.0 Hz, 3H), 1.54 (s, 3H), 1.34 (s, 3H) ppm. 
B) 1,2-O-isopropylidene-3-azido-3-deoxy--D-ribofuranuronic acid (6) (0.50 g; 2.2 mmol) was 
dissolved in dry DMF (26.4 ml) and cooled to -15 C. Triethylamine (0.35 ml) and isobutyl 
chloroformate (0.32 ml) were dropped to the solution and stirred. The temperature was kept between -
10 - 
-15 °C. (Solution I.) Methylamine in THF (1.12 ml, 2M) included TEA (0.35 ml) (Solution II.) 
was cooled to 0 C and added to the Solution I. after 20 min. The reaction mixture was stirred for an 
hour between -10-
-15 °C and even an hour at 0 °C, then pH was checked (pH 7-8). The precipitate 
(TEA.HCl) was filtered, washed with cool DMF. The solvent was removed, the residue was dissolved 
in EtOAc (20 ml) and extracted with cool distilled water (2x10 ml), HCl solution (2x10 ml, 2N), 
saturated solution of NaHCO3 (2x10 ml) and brine (2x10 ml). The organic phase was dried (MgSO4) 
and concentrated in vacuo. The crude product was isolated and purified by column chromatography 
(hexane-EtOAc 1:2) to give white crystals (0.13 g; 25 %). Spectral and chromatographic data of the 
product are in agreement with the data of the product by A). 
N-methyl-1,2-O-isopropylidene-3-azido-3-deoxy--D-xylofuranuronamide (30): 
From 7 (0.5 g; 2.2 mmol) the reaction was carried out with the same method as the formation of 31 
with method B). The product 30 was pale yellow oil (0.24 g; 46 %). Rf = 0.4 (EtOAc‒hexane 1:1); 
FTIR-ATR: νmax: 3349 ( NH), 2106 ( N3), 1645 (amide I,  C=O), 1535 (amide II) cm
-1
. ESI-MS: 
243.2 [M+H]
+
, calculated: 242.2 m/z; 
1
H NMR (CDCl3, 250 MHz) δ = 6.45 (broad m, 1H), 5.87 (d, J= 
3.32 Hz, 1H), 4.70 (d, J= 3.45 Hz, 1H), 4.55 (m, 1H), 4.34 (d, J= 3.43, 1H), 2.83 (d, J= 4.95 Hz, 3H), 
1.51 (s, 3H), 1.27 (s, 3H) ppm. 
N-methyl-1,2-O-isopropylidene-3-amino-3-deoxy-α-D-ribofuranuronamide (28): 
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A) N-methyl-1,2-O-isopropylidene-3-azido-3-deoxy-α-D-ribofuranuronamide (31) (0.24 g; 0.99 
mmol) was dissolved in methanol (28.0 ml, c= 35 mmol/l) and reduced with H2 on 10 % Pd/C by H-
Cube (parameters: 60 °C, 10 bar, 0.2 ml/min). After the reaction, the solution was concentrated in 
vacuo to give the product 28 as pale yellow oil (0.18 g; 85 %). Rf = 0.86 (chloroform‒methanol 3:1); 
FTIR-ATR: νmax: 3375 and 3353 (ν NH2 and NH), 1652 (amide I), 1545 (amide II) cm
-1
; ESI-MS: 
217.2 [M+H]
+
, calculated: 216.2 m/z; 
1
H NMR (CDCl3, 250 MHz) δ = 6.44 (broad m, 1H), 6.00 (d, J= 
3.4 Hz, 1H), 4.80 (t, J= 4.4 Hz, 2H), 4.54 (d, J= 9.5 Hz, 1H), 2.81 (d, J= 5.0 Hz, 3H), 1.43 (s, 3H), 
1.27 (s, 3H) ppm. 
B) N-methyl-1,2-O-isopropylidene-3-azido-3-deoxy-α-D-ribofuranuronamide (31) (0.16 g; 0.67 
mmol) was dissolved in dry pyridine (6 ml) and triphenylphosphine (0.34 g; 1.3 mmol) was added to 
the solution. The reaction mixture was allowed to stand for two hours at room temperature. 
Ammonium hydroxide solution (2.3 ml, 25 %) was dropped to the mixture and it was allowed to stand 
for 3.5 h. The solution was filtered and concentrated in vacuo. The residue was treated with aqueous 
ammonia (12 %) and the solid containing triphenylphosphine and triphenylphosphine oxide was 
removed by filtration. Evaporation of the aqueous solution gave pale yellow oil as homogeneous 
product 28 (0.15 g; 92 %). Spectral and chromatographic data of the product are in agreement with the 
data of the product from the H-Cube reactor. 
N-methyl-1,2-O-isopropylidene-3-amino-3-deoxy--D-xylofuranuronamide (29): 
N-methyl-1,2-O-isopropylidene-3-azido-3-deoxy--D-xylofuranuronamide (30) (0.31 g; 1.3 mmol) 
was dissolved in methanol (37 ml, 35 mmol/L). The starting material was reduced with H2 on 10 % 
Pd/C by H-Cube (parameters: 70 °C, 10 bar, 0.2 ml/min). The reaction time was 6 h to give a 
colourless oil (0.30 g; 95 %). Rf = 0.83 (chloroform‒methanol 3:1); FTIR-ATR: νmax: 3340 (ν NH2 and 
NH), 1655 (amide I), 1544 (amide II) cm
-1
; ESI-MS: 217.2 [M+H]
+
, calculated: 216.2 m/z; 
1
H NMR 
(CDCl3, 250 MHz) δ = 6.45 (broad m, 1H), 6.00 (d, J= 3.25 Hz, 1H), 4.81 (dd, J= 3.21 Hz, 2H), 4.54 
(d, J= 3.17 Hz, 1H), 2.81 (d, J= 5.02 Hz, 3H), 1.43 (s, 3H), 1.27 (s, 3H) ppm. 
N-methyl-1,2-O-isopropylidene-3-acetamido-3-deoxy-α-D-ribofuranuronamide (26): 
N-methyl-1,2-O-isopropylidene-3-amino-3-deoxy-α-D-ribofuranuronamide (28) (0.03 g; 0.14 mmol) 
was dissolved in cold mixture of pyridine (0.17 ml) and acetic anhydride (0.1 ml). The reaction 
mixture was allow to stand at 0 °C for 2 days. The solution was dropped to ice ‒ water (5 ml) and 
concentrated in vacuo. The crude product was crystallized from ethyl acetate – petroleum ether to give 
white crystals (0.02 g; 56 %). M.p.: 208-210 °C; Rf = 0.62 (chloroform‒methanol 3:2); FTIR-ATR: 
νmax: 3391 and 3324 (ν NH), 1655 (amide I), 1546 (amide II) cm
-1
; ESI-MS: 259.2 [M+H]
+
, calculated: 
258.2 m/z;
 1
H NMR (CDCl3, 700 MHz) δ = 6.42 (broad m, 1H), 6.08 (d, J= 7.2 Hz, 1H), 5.79 (d, J= 
3.4 Hz, 1H), 4.70 (t, J= 4.2 Hz, 1H), 4.23 (ddd, J= 4.2 Hz, J= 10.2 Hz, J= 7.2 Hz, 1H), 4.17 (d, J= 
10.2 Hz, 1H), 2.78 (d, J= 5.0 Hz, 3H), 2.00 (s, 3H), 1.48 (s, 3H), 1.28 (s, 3H) ppm. 
N-methyl-1,2-O-isopropylidene-3-acetamido-3-deoxy-α-D-xylofuranuronamide (27): 
From 29 (0.04 g; 0.18 mmol) the reaction was carried out with the same method as the formation of 
26. The product 27 was colourless yellow oil (0.015 g; 31 %). Rf = 0.70 (chloroform‒methanol 3:2); 
FTIR-ATR: νmax: 3293 ( NH), 1654 (amide I,  C=O), 1544 (amide II) cm
-1
; ESI-MS: 259.2 [M+H]
+
, 
calculated: 258.2 m/z; 
1
H NMR (CDCl3, 250 MHz) δ = 6.83 (m, 1H), 6.61 (m, 1H), 6.04 (m, 1H), 4.73 
(m, 2H), 4.41 (m, 1H), 2.78 (d, 3H), 1.90 (s, 3H), 1.43 (s, 3H), 1.25 (s, 3H) ppm. 
 
Synthesis of sugar amino acid dipeptide 
3-Azido-3-deoxy-1,2-O-isopropylidene-α-D-ribofuranuronil-N-methyl-1,2-O-isopropylidene-D-
ribofuranuronamide (32): 
1,2-O-isopropylidene-3-azido-3-deoxy--D-ribofuranuronic acid (6) (0.95 g; 0.42 mmol) was 
dissolved in dry DMF (2.5 ml) and cooled at -15 C. Triethylamine (80 µl) and isobutyl chloroformate 
(75 µl) were dropped to the solution and stirred. The temperature was kept between -10 - -15 °C for 40 
min (Solution I.). N-methyl-1,2-O-isopropylidene-3-amino-3-deoxy-α-D-ribofuranuronamide (28) 
(0.09 g; 0.42 mmol) included TEA (80 µl) (Solution II.) was cooled to 0 C and added to the Solution 
I. The reaction mixture was stirred for an hour between -10-
-15 °C and even an hour at 0 °C, then pH 
was checked (pH 7-8). The precipitate (TEA.HCl) was filtered, washed with cool DMF. The solvent 
was removed. The crude product was isolated and purified by column chromatography (hexane-EtOAc 
1:1) to give white crystals (0.07 g; 37 %). M.p.: 171-174 °C; Rf = 0.40 (EtOAc); FTIR-ATR: νmax: 
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3362 and 3229 (ν NH), 2110 (ν N3), 1681 (ν C=O), 1652 (amide I), 1525 (amide II) cm
-1
. ESI-MS: 
428.3 [M+H]
+
, calculated: 427.41 m/z. 
1
H NMR (CDCl3, 250 MHz) δ = 6.86 (broad d, J=7.9 Hz, 1H), 
6.36 (broad m, 1H), 5.83 (d, J= 3.5, 1H), 5.81 (d, J= 3.5 Hz, 1H), 4.66 (t, J= 4.4 Hz, 1H), 4.64 (t, J= 
4.2 Hz, 1H), 4.50 (d, J = 9.5 Hz, 1H), 4.23 (ddd, J= 4.2 Hz, J= 9.9 Hz, J= 7.2 Hz, 1H), 4.17 (t, J= 9.9 
Hz, 1H), 3.63 (dd, J= 4.4 Hz, J= 9.5 Hz, 1H), 2.76 (d, J= 5.0 Hz, 3H), 1.51 (s, 3H), 1.48 (s, 3H), 1.31 
(s, 3H), 1.28 (s, 3H) ppm. 
 
Synthesis of N-protected derivatives 
1,2-O-isopropylidene-N-(9-fluorenylmethoxy-carbonyl)-3-amino-3-deoxy-α-D-ribofuranuronic 
acid (33) 
The stirred solution of 1,2-O-isopropylidene-3-amino-3-deoxy-α-D-ribofuranuronic acid (1) (0.20 g; 
0.99 mmol) in methanol – water 2:1 (6.6 ml) is adjusted to pH 8 with saturated NaHCO3 solution. The 
solution of Fmoc-OSu (0.37 g; 1.1 mmol; 1.1 eqv.) in THF (6.8 ml) was added to this solution and 
stirred for 48 hours at room temperature. Solvents were removed in vacuo. The residue was suspended 
in water and extracted with EtOAc (3x). The combined organic phases were washed with NaHCO3. 
The aqueous phase is adjusted to pH 1 with 2N HCl and extracted with EtOAc (3x). The organic phase 
is washed with saturated NaCl solution, dried (MgSO4) and concentrated in vacuo.  The product 
formed colourless oil (0.21 g; 51 %). Rf = 0.50 (ethyl-acetate–methanol 4:1); FTIR-ATR: νmax: 3500-
2400 (ν COOH), 3349 ( NH), 1719 ( C=O), 1691 ( aromatic), 1600 (amide I), 1523 (amide II) cm-
1
;
 
ESI-MS: 426.2 [M+H]
+
, calculated: 425.19 m/z. 
1
H NMR (DMSO-d6, 250 MHz) δ = 7.74 (m, 5H), 
7.36 (m, 5H),  5.85 (d, J= 3.29 Hz, 1H), 4.61 (m, 1H), 4.28 (m, 3H), 4.06 (m, 1H), 1.46 (s, 3H), 1.26 
(s, 3H) ppm. 
1,2-O-isopropylidene-N-(9-fluorenylmethoxy-carbonyl)-3-amino-3-deoxy-α-D-xylofuranuronic 
acid (34) 
From 1,2-O-isopropylidene-3-amino-3-deoxy-α-D-xylofuranuronic acid (2) (0.13 g; 0.64 mmol) the 
reaction was carried out with the same method as the formation of (33).The product formed colourless 
oil (0.13 g; 49 %). Rf = 0.52 (ethyl-acetate–methanol 4:1); FTIR-ATR: νmax: 3500-2400 (ν COOH), 
1719 (broad,  C=O,  aromatic, amide I), 1519 (amide II) cm-1;  ESI-MS: 426.2 [M+H]+, calculated: 
425.19 m/z. 
1
H NMR (CDCl3, 250 MHz) δ = 7.55 (m, 3H), 7.30 (overlapped by the signal of CDCl3),  
6.08 (d, J= 3.07 Hz, 1H), 4.97 (d, J= 3.27 Hz, 1H), 4.85 (d, J= 3.26 Hz, 1H), 4.46 (d, J= 3.36 Hz, 1H), 
3.82 (m, 1H), 3.44 (m, 1H), 1.45 (s, 3H), 1.28 (s, 3H) ppm. 
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Figure captions: 
Figure 1 The two central key products applied for further syntheses are H-RibAFU(ip)-OH (1, H-tX-
OH) and H-XylAFU(ip)-OH (2, H-cX-OH). 
 
Figure 2 Selected key Lego-modules of water soluble β-sugar amino acids, 6 and 7 made 
resourcefully from D-Glc. 
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Scheme captions: 
Scheme 1 General synthetic pathway of 3-amino-3-deoxy-pentofuranuronic acids (1 and 2) from 
diaceton-glucofuranose (3) 
Scheme 2 Synthesis of 1,2:5,6-di-O-isopropylidene-3-azido-3-deoxy-D-allofuranose. Reagents and 
conditions: a) Tf2O, Py, CH2Cl2; b) MsCl, Py; c) NaH, DMF, Im2SO2; d) TsCl, Py; e) NaN3, DMSO, 
140-145°C; f) NaN3, DMSO, Bu4NBr, 80 °C; g) NaN3, DMF, room temperature 
Scheme 3 Synthesis of 1,2:5,6-di-O-isopropylidene-3-azido-3-deoxy-D-glucofuranose. Reagents and 
conditions: a) (i) PCC, DCM; (ii) NaBH4, EtOH-H2O or (i) TEMPO, BAIB, DCM; (ii) NaBH4, EtOH-
H2O; b) Tf2O, Py, CH2Cl2; c) MsCl, Py; d) NaH, DMF, Im2SO2; e) TsCl, Py; f) NaN3, DMSO, 120 °C; 
g) NaN3, toluene, Bu4NBr, 80-90 °C; h) NaN3, DMSO, 135°C 
Scheme 4 Competing substitution and elimination reaction for 3-O-tosylates. Reagents and 
conditions: a) NaN3, DMSO, 135-145°C; b) AcOH–H2O 3:1; c) NaIO4, MeOH; d) KMnO4, AcOH–
H2O 1:1; e) CH2N2/Et2O, DCM; f) NaN3, DMSO, 80°C 
Scheme 5 Synthesis of N3-RibAFU(ip)-OH and N3-XylAFU(ip)-OH. Reagents and conditions: a) 
AcOH–H2O 3:1; b) NaIO4, MeOH; c) KMnO4, AcOH–H2O 1:1 
Scheme 6 The ultimate simplified reaction route to make azido-furanuronic acids as foldameric 
building blocks. Used reagents: a) Im2SO2; b) NaN3; c) AcOH; d) NaIO4 and KMnO4 
Scheme 7 Synthesis of AFU diamides for both C3-epimers. Reagents and conditions: a) (i) oxalyl 
chloride,  DMF, THF, (ii) 2M MeNH2/THF; b) (i) ClCOO
i
Bu, Et3N, DMF, (ii) 2M MeNH2/THF; c) H-
Cube® H2, CH3OH, 10% Pd/C d) Ac2O–pyridine 
Scheme 8 Coupling of sterically hindered trans-β-furanoid SAA dipeptide, namely N3-RibAFU(ip)-
RibAFU(ip)-NHMe. Reagents and conditions: a) ClCOO
i
Bu, Et3N, DMF, -15 °C 
Scheme 9 Synthesis of Fmoc protected β-amino acid derivatives (Fmoc-RibAFU(ip)-OH and Fmoc-
XylAFU(ip)-OH) for solid phase peptide synthesis. Reagents and conditions:  a) H-Cube® H2, 
CH3OH, 10% Pd/C, b) MeOH-H2O 2:1, NaHCO3, Fmoc-OSu / THF 
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Table caption: 
Table 1 Yields and costs of the synthesis of allofuranose (4) and glucofuranose (5) 
 
 
 
 
